Pharsight

Drugs that contain Calcium Acetate

1. Phoslo patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6576665 FRESENIUS MEDCL Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
Apr, 2021

(3 years ago)

Market Authorisation Date: 02 April, 2001

Treatment: NA

Dosage: CAPSULE;ORAL

How can I launch a generic of PHOSLO before it's drug patent expiration?
More Information on Dosage

PHOSLO family patents

Family Patents

2. Phoslo Gelcaps patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6576665 FRESENIUS MEDCL Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
Apr, 2021

(3 years ago)

US6875445 FRESENIUS MEDCL Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
Jul, 2021

(2 years ago)

Market Authorisation Date: 02 April, 2001

Treatment: NA

Dosage: CAPSULE;ORAL

How can I launch a generic of PHOSLO GELCAPS before it's drug patent expiration?
More Information on Dosage

PHOSLO GELCAPS family patents

Family Patents

3. Phoslyra patents expiration

PHOSLYRA Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8592480 FRESENIUS MEDCL Liquid compositions of calcium acetate
Jul, 2027

(3 years from now)

US9089528 FRESENIUS MEDCL Liquid compositions of calcium acetate
Jul, 2027

(3 years from now)

US8591938 FRESENIUS MEDCL Liquid compositions of calcium acetate
Feb, 2030

(5 years from now)

Market Authorisation Date: 18 April, 2011

Treatment: Use of phoslyra for reduction of serum phosphorous in patients

Dosage: SOLUTION;ORAL

How can I launch a generic of PHOSLYRA before it's drug patent expiration?
More Information on Dosage

PHOSLYRA family patents

Family Patents